Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib

Press/Media: Press / Media

PeriodMar 8 2024

Media coverage

1

Media coverage

  • TitleActivation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib
    Media name/outletMOLECULAR CANCER
    Country/TerritoryUnited Kingdom
    Date3/8/24
    PersonsHao Chen
View all 1
View less